Mineralys Therapeutics (MLYS) Change in Interest Receivables (2023 - 2026)
Quarterly results put Change in Interest Receivables at -$289000.0 for Q1 2026, down 455.77% from a year ago — trailing twelve months through Mar 2026 was -$71000.0 (up 80.11% YoY), and the annual figure for FY2025 was $166000.0, up 139.15%.
Mineralys Therapeutics has reported Change in Interest Receivables over the past 4 years, most recently at -$289000.0 for Q1 2026.
- Change in Interest Receivables reached -$289000.0 in Q1 2026 per MLYS's latest filing, down from $181000.0 in the prior quarter.
- Across five years, Change in Interest Receivables topped out at $270000.0 in Q1 2023 and bottomed at -$300000.0 in Q4 2023.
- Median Change in Interest Receivables over the past 4 years was -$23000.0 (2024), compared with a mean of -$14769.2.
- The largest annual shift saw Change in Interest Receivables soared 284.69% in 2025 before it plummeted 455.77% in 2026.
- Over 4 years, Change in Interest Receivables stood at -$300000.0 in 2023, then surged by 67.33% to -$98000.0 in 2024, then skyrocketed by 284.69% to $181000.0 in 2025, then plummeted by 259.67% to -$289000.0 in 2026.
- Business Quant data shows Change in Interest Receivables for MLYS at -$289000.0 in Q1 2026, $181000.0 in Q4 2025, and -$10000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Interest Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | - |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | - |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | - |
| 10 | Mineralys Therapeutics | 2.50 Bn | 2.50 Bn | - | -289,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -289,000.00 |
| Dec 31, 2025 | 181,000.00 |
| Sep 30, 2025 | -10,000.00 |
| Jun 30, 2025 | 47,000.00 |
| Mar 31, 2025 | -52,000.00 |
| Dec 31, 2024 | -98,000.00 |
| Sep 30, 2024 | -23,000.00 |
| Jun 30, 2024 | -184,000.00 |
| Mar 31, 2024 | -119,000.00 |
| Dec 31, 2023 | -300,000.00 |
| Sep 30, 2023 | 219,000.00 |
| Jun 30, 2023 | 166,000.00 |
| Mar 31, 2023 | 270,000.00 |